tiprankstipranks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
MDNAF
Medicenna Therapeutics Corp
RESEARCH TOOLSreports

Medicenna Therapeutics Corp (MDNAF) Income Statement

253 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q3 2026), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Medicenna Therapeutics Corp's net income was C$-4.36M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -55.00KC$ -5.00KC$ -38.00KC$ -40.00KC$ -6.82K
Operating Expenses
C$ 21.58MC$ 19.66MC$ 22.47MC$ 17.39MC$ 4.73M
Depreciation and Amortization
C$ 55.00KC$ 5.00KC$ 38.00KC$ 40.00KC$ 6.82K
EBITDA
C$ -12.97MC$ -18.67MC$ -22.54MC$ -17.25MC$ -4.70M
Operating Income
C$ -21.63MC$ -19.66MC$ -22.30MC$ -17.19MC$ -4.73M
Other Income/Expenses
C$ 8.60MC$ -5.80MC$ 1.65MC$ 106.00KC$ 5.16M
Pretax Income
C$ -13.03MC$ -25.47MC$ -22.58MC$ -17.29MC$ -4.71M
Net Income
C$ -11.80MC$ -25.47MC$ -22.65MC$ -17.18MC$ -4.71M
Per Share Metrics
Basic EPS
C$ -0.15C$ -0.37C$ -0.42C$ -0.35C$ -0.18
Diluted EPS
C$ -0.15C$ -0.37C$ -0.42C$ -0.35C$ -0.18
Weighted Average Shares Outstanding
 76.67M 69.64M 54.29M 49.66M 25.67M
Weighted Average Shares Outstanding (Diluted)
 76.67M 69.64M 54.29M 49.66M 25.67M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History